Recruiting now
-
Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer
Phase 3 · randomised · 556 people · 1 site in China · Recruiting now
-
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Phase 2 · randomised · 136 people · 28 sites in 4 countries · Recruiting now
-
Short-Course Radiotherapy Followed by Immunotherapy Combined With Chemotherapy for Microsatellite Stable Locally Advanced Rectal Cancer: A Prospective, Randomized, Controlled Phase II Clinical Trial
Phase 2 · randomised · 130 people · 1 site in China · Recruiting now
-
Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC
Phase 2 · randomised · 138 people · 1 site in China · Recruiting now
-
Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance
Phase 3 · randomised · 140 people · 5 sites in Switzerland · Recruiting now
-
Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
Phase 2 · randomised · 353 people · 6 sites in Netherlands · Recruiting now